Home Newsfeeds HC Wainwright & Co. Downgrades Neovasc to Neutral

HC Wainwright & Co. Downgrades Neovasc to Neutral

HC Wainwright & Co. analyst Vernon Bernardino downgrades Neovasc (NASDAQ:NVCN) from Buy to Neutral.

byBenzinga Newsdesk

January 18, 2023

1 minute read

HC Wainwright & Co. analyst Vernon Bernardino downgrades Neovasc (NASDAQ:NVCN) from Buy to Neutral.

Why Are Shares of Exxon Mobil Rising Today?

By Dylan Wechsler

July 29, 8:55 AM

Shares of Exxon Mobil Corp (NYSE: XOM) are trading higher today following a strong earnings report. Exxon reported $17.9 billion in total earnings for the second quarter which is an increase from $5.480 billion reported in the first quarter.

XOM

Analyst Ratings

7 Analysts Have This to Say About Casey’s General Stores

By Benzinga Insights

December 7, 10:03 AM

Casey’s General Stores (NASDAQ:CASY) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent…

CASY

Morgan Stanley Maintains Equal-Weight on Nucor, Raises Price Target to $131

By Benzinga Newsdesk

March 20, 7:45 AM

Morgan Stanley analyst Carlos De Alba maintains Nucor (NYSE:NUE) with a Equal-Weight and raises the price target from $122 to $131.

NUE

Why NextGen Healthcare Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket

By Lisa Levin

September 5, 8:11 AM

Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) rose 65.3% to $12.20 in pre-market trading after gaining around 9% on Friday.

$SRM

HC Wainwright & Co. Downgrades Neovasc to Neutral

Related Posts

Why Are Shares of Exxon Mobil Rising Today?

7 Analysts Have This to Say About Casey’s General Stores

Morgan Stanley Maintains Equal-Weight on Nucor, Raises Price Target to $131

Why NextGen Healthcare Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket